why choose us

First received: March 09, 2023

Clinical Trial: Dose Reduction and Discontinuation With Anti-Fibrotic Medications

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Idiopathic Pulmonary Fibrosis

Study Type: OBSERVATIONAL


Official Title: Assessment of the Dose Reduction and Discontinuation Associated With Anti-Fibrotic Medications in Patients With Idiopathic Pulmonary Fibrosis

Brief Summary: The overarching aim of our study is to assess the incidence of dose reduction and discontinuations for pirfenidone and nintedanib.

Read more